Praxis Precision Medicines (PRAX) Stock Statistics & Valuation Metrics

Praxis Precision Medicines has a market cap or net worth of $946.01M. The enterprise value is $602.50M.

Praxis Precision Medicines has 21,045,780 shares outstanding. The number of shares has decreased by -2.65% in one year.

Praxis Precision Medicines’s return on equity (ROE) is -0.41 and return on invested capital (ROIC) is -44.80%.

The current PE Ratio of Praxis Precision Medicines is ―. Praxis Precision Medicines’s PEG ratio is 0.17.

In the last 12 months, Praxis Precision Medicines had revenue of 8.55M and earned -182.82M in profits. Earnings per share was -10.21.

In the last 12 months, operating cash flow was -191.31M and capital expenditures -56.00K, giving a free cash flow of -191.36M billion.

Praxis Precision Medicines pays an annual dividend of ―, resulting in a dividend yield of ―

Praxis Precision Medicines upcoming earnings date is Nov 5, 2025, Before Open (Confirmed).

Praxis Precision Medicines as a current ratio of 10.77, with Debt / Equity ratio of 0.19%

In the past 12 months, Praxis Precision Medicines has paid 0.00 in taxes.

Praxis Precision Medicines EV to EBITDA ratio is -5.83, with an EV/FCF ratio of -8.84.

Praxis Precision Medicines has $301.27M in cash and marketable securities with $755.00K in debt, giving a net cash position of -$300.52M billion.

Gross margin is 99.39%, with operating margin of -2340.29%, and net profit margin of -2137.48%.

The average price target for Praxis Precision Medicines is $106.33, which is 11.43% higher than the current price. The consensus rating is Moderate Buy